Respiratory Infection and the Decision to Delay Surgery
Recent respiratory infection adds +17 points to ARISCAT — the highest-weighted single factor. When to delay, how long to wait, and what to do while waiting.
My patient had a respiratory infection three weeks ago — can we proceed with elective surgery?
Recent infection adds +17 points to ARISCAT — the single highest-weighted factor. Symptom resolution does not mean the airway has recovered.
Key points
A respiratory infection within the past month is the single highest-weighted ARISCAT factor (+17 points). For elective surgery, waiting for full airway recovery is almost always worth it. Symptoms resolving does not mean the airway has recovered.
Why respiratory infection substantially increases operative risk
The airways remain in a vulnerable state for weeks after respiratory infection, even after clinical symptoms have resolved. This understanding is the basis for the decision to delay.
- Airway hyperresponsiveness — the airway remains hypersensitive to the stimuli of intubation, suction, and volatile agents, increasing bronchospasm risk
- Increased secretion burden — mucus production is elevated, impairing mucociliary clearance and increasing the risk of secretion retention and atelectasis
- Mucociliary dysfunction — the airway's self-clearing mechanism remains impaired beyond symptom resolution
- Persistent airway inflammation — subclinical inflammatory activity continues even after the patient feels well
- Bacterial colonisation — bacterial load from the infection may persist and manifest postoperatively as pneumonia
Types of respiratory infection and how long to wait
| Type of infection | Risk level | Recommended waiting period |
|---|---|---|
| Upper respiratory tract infection (URTI) | Moderate. Low risk of lower airway involvement | Proceed if there is no fever, no purulent discharge, and symptoms are resolving. If symptomatic, wait until asymptomatic plus 2 weeks |
| Lower respiratory tract infection (LRTI) / acute bronchitis | High. Direct lower airway inflammation | Wait until symptoms have fully resolved, then allow 4 weeks for airway recovery |
| Pneumonia (confirmed) | Highest. Parenchymal lung involvement | Wait for clinical resolution and X-ray normalisation, then 4–8 weeks |
| Viral (influenza, parainfluenza) | High. Airway hyperresponsiveness is prolonged | Minimum 4 weeks after symptoms resolve; 6 weeks for high-risk patients |
| COVID-19 | High, with multi-organ considerations and thrombotic risk | 7 weeks after symptom resolution is recommended (AAGBI 2022 guidance) |
Symptom resolution and airway recovery are not the same
Fever and cough resolving within a week does not mean the airway is ready for surgery. Airway hyperresponsiveness and mucociliary dysfunction typically persist for 2–4 weeks after symptoms disappear. The ARISCAT cutoff is 1 month — the airway needs more than a few days of feeling well.
Decision framework for elective surgery
- Any current fever, cough, purulent sputum, or reduced SpO₂ → delay elective surgery
- Symptoms resolved less than 2 weeks ago → delay for most cases (upper airway: clinical judgement; lower airway or pneumonia: delay)
- Symptoms resolved 2–4 weeks ago → continue to delay lower airway infection and pneumonia; upper airway infection can proceed with careful assessment
- Symptoms resolved more than 4 weeks ago → proceed in most cases; confirm full recovery
- COVID-19 → apply the 7-week recommendation regardless of symptom severity
When surgery cannot be delayed
Emergency surgery does not allow time for airway recovery. The approach shifts to risk-informed management: meticulous airway technique, adequate suction, lung-protective ventilation throughout, and enhanced postoperative monitoring as a high-risk patient.
Emergency surgery with active infection: plan for complications
Consider rapid sequence induction if aspiration risk is elevated. Prepare for bronchospasm on induction. Plan postoperative ICU or HDU admission for monitoring. The risk cannot be eliminated — it can only be managed.
During the waiting period
- Treat any confirmed bacterial infection with antibiotics
- Optimise inhaler therapy to reduce airway hyperresponsiveness and secretion burden
- Enforce smoking cessation — smoking during recovery prolongs mucociliary dysfunction
- Nutritional support to facilitate immune recovery
- Begin preoperative respiratory physiotherapy where feasible — improves baseline lung function before surgery
- Calculate ARISCAT Risk Score
Respiratory infection is scored alongside six other factors
- Interpreting preoperative SpO2 reduction
Infection-related SpO₂ reduction and its management
- Postoperative pulmonary complications: classification and definitions
Understanding why infection increases the PPC cascade risk
Written by
Kozo Watanabe, MD
Chief of Anesthesiology
Practicing anesthesiologist specializing in cardiovascular anesthesia and perioperative management. Clinical focus includes perioperative risk assessment, respiratory and hemodynamic management, and decision support for high-risk surgical patients.
- Cardiovascular anesthesia and cardiac surgery
- Perioperative critical care
- Perioperative respiratory management (oxygenation, ventilation, ABG interpretation)